drugset / Trial / NCT02016482
A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being conducted to assess the safety and efficacy of adalimumab in participants with nail psoriasis.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-10
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |